http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-107987179-B
Outgoing Links
Predicate | Object |
---|---|
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C08B37-0003 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-737 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C08B37-006 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-737 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P37-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C08B37-00 |
filingDate | 2017-12-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate | 2020-07-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationDate | 2020-07-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | CN-107987179-B |
titleOfInvention | Application of low-sulfated fucan in preparation of immunopotentiator |
abstract | The invention relates to a preparation method and application of low sulfated fucan derived from marine brown algae. The low sulfated fucogalactan mainly comprises monosaccharide including galactose, fucose, glucose, etc., has weight average molecular weight of 5-30KD, and has hydrolyzed sulfate group content of 15-20%, galactose content of 40-45%, fucose content of 20-25%, and ratio of galactose content to fucose content of 2: 1. The low sulfated fucogalactan is derived from Laminaria japonica of brown algae, and has effect of activating macrophage in mouse abdominal cavity to release nitric oxide. |
priorityDate | 2017-12-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 45.